Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EAPI.PA
- Price
- 2.39
- Stock movement up
- +0.04 (1.53%)
- Company name
- Euroapi SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 227.30M
- Ent value
- 850.90M
- Price/Sales
- 0.19
- Price/Book
- 0.26
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -7.81%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
EAPI.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 1.72 |
| Price to FCF | - |
| Price to EBITDA | 1.33 |
| EV to EBITDA | 4.98 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.19 |
| Price to Book | 0.26 |
| EV to Sales | 0.69 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 95.26M |
| EPS (TTM) | -4.39 |
| FCF per share (TTM) | -0.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.23B |
| Gross profit (TTM) | 196.25M |
| Operating income (TTM) | -29.75M |
| Net income (TTM) | -413.55M |
| EPS (TTM) | -4.39 |
| EPS (1y forward) | -0.17 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 15.99% |
| Operating margin (TTM) | -2.42% |
| Profit margin (TTM) | -33.68% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 282.80M |
| Net receivables | 215.80M |
| Total current assets | 1.16B |
| Goodwill | 4.60M |
| Intangible assets | 38.90M |
| Property, plant and equipment | 2.42B |
| Total assets | 1.80B |
| Accounts payable | 143.60M |
| Short/Current long term debt | 471.60M |
| Total current liabilities | 735.90M |
| Total liabilities | 906.40M |
| Shareholder's equity | 889.50M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 132.05M |
| Capital expenditures (TTM) | 160.35M |
| Free cash flow (TTM) | -28.30M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -46.49% |
| Return on Assets | -23.03% |
| Return on Invested Capital | -30.71% |
| Cash Return on Invested Capital | -2.10% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.39 |
| Daily high | 2.41 |
| Daily low | 2.30 |
| Daily Volume | 63K |
| All-time high | 18.71 |
| 1y analyst estimate | 3.38 |
| Beta | 0.56 |
| EPS (TTM) | -4.39 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EAPI.PA | S&P500 | |
| Current price drop from All-time high | -87.25% | -12.89% |
| Highest price drop | -87.71% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -51.46% | -11.07% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 636 days | 1805 days |
COMPANY DETAILS
Marketcap
227.30M
Marketcap category
Small-cap
Description
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.
Employees
3650
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Press Release Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers (AMF) on April...
April 1, 2025
Despite a challenging year with decreased sales and EBITDA, Euroapi SA (EAPIF) shows resilience through strategic client acquisitions and sustainability commitments.
March 5, 2025
Press Release Paris, 3rd March, 2025 Full-year 2024 results1: Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...
March 3, 2025
Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI’s long-term commitment to health sovereignty Paris and Vertolaye - January 6, 2025 – The French Minister for ...
January 6, 2025
Press Release Emmanuel Blin appointed Independent Chair of the Board of DirectorsDavid Seignolle appointed Chief Executive OfficerFull-year 2024 guidance maintained Paris – December 9, 2024 – With FOC...
December 9, 2024
Press Release Paris – October 16, 2024 – Olivier Falut has been appointed EUROAPI’s Chief Financial Officer, effective October 17, 2024, and will be a member of the Executive Committee. He is taking o...
October 16, 2024
Press Release Paris - 15 October 2024 - EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, th...
October 15, 2024
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi€54M product capacit...
October 10, 2024
Despite a decline in net sales and core EBITDA, Euroapi SA (EAPIF) focuses on strategic projects and financial discipline to drive future growth.
October 9, 2024
Paris, 05 August, 2024 – EUROAPI posted today its 2024 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2024. This document is available for consultation and dow...
August 5, 2024
Next page